» Articles » PMID: 33843445

Pathogenicity and Virulence of West Nile Virus Revisited Eight Decades After Its First Isolation

Overview
Journal Virulence
Specialty Microbiology
Date 2021 Apr 12
PMID 33843445
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

West Nile virus (WNV) is a flavivirus which transmission cycle is maintained between mosquitoes and birds, although it occasionally causes sporadic outbreaks in horses and humans that can result in serious diseases and even death. Since its first isolation in Africa in 1937, WNV had been considered a neglected pathogen until its recent spread throughout Europe and the colonization of America, regions where it continues to cause outbreaks with severe neurological consequences in humans and horses. Although our knowledge about the characteristics and consequences of the virus has increased enormously lately, many questions remain to be resolved. Here, we thoroughly update our knowledge of different aspects of the WNV life cycle: virology and molecular classification, host cell interactions, transmission dynamics, host range, epidemiology and surveillance, immune response, clinical presentations, pathogenesis, diagnosis, prophylaxis (antivirals and vaccines), and prevention, and we highlight those aspects that are still unknown and that undoubtedly require further investigation.

Citing Articles

Survey of West Nile virus infection in wildlife species in the Orinoquia region of Colombia.

Matta N, Gaitan-Albarracin F, Fuentes-Rodriguez G, Rodriguez-Fandino O, Calixto-Botia I, Correa-Higuera L Front Microbiol. 2025; 16:1548538.

PMID: 40071208 PMC: 11893598. DOI: 10.3389/fmicb.2025.1548538.


An Inactivated West Nile Virus Vaccine Candidate Based on the Lineage 2 Strain.

Vorovitch M, Tuchynskaya K, Kruglov Y, Peunkov N, Mostipanova G, Kholodilov I Vaccines (Basel). 2025; 12(12.

PMID: 39772058 PMC: 11680355. DOI: 10.3390/vaccines12121398.


West Nile Virus in a changing climate: epidemiology, pathology, advances in diagnosis and treatment, vaccine designing and control strategies, emerging public health challenges - a comprehensive review.

Singh P, Khatib M, Ballal S, Kaur M, Nathiya D, Sharma S Emerg Microbes Infect. 2024; 14(1):2437244.

PMID: 39614679 PMC: 11703391. DOI: 10.1080/22221751.2024.2437244.


Biosensors for the detection of flaviviruses: A review.

Blazquez A, Jimenez de Oya N Synth Syst Biotechnol. 2024; 10(1):194-206.

PMID: 39552759 PMC: 11564047. DOI: 10.1016/j.synbio.2024.10.005.


Antiviral Effects of Avian Interferon-Stimulated Genes.

He X, Zhang S, Zou Z, Gao P, Yang L, Xiang B Animals (Basel). 2024; 14(21).

PMID: 39518785 PMC: 11545081. DOI: 10.3390/ani14213062.


References
1.
Gack M, Diamond M . Innate immune escape by Dengue and West Nile viruses. Curr Opin Virol. 2016; 20:119-128. PMC: 5578430. DOI: 10.1016/j.coviro.2016.09.013. View

2.
Morrey J, Taro B, Siddharthan V, Wang H, Smee D, Christensen A . Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res. 2008; 80(3):377-9. PMC: 2587511. DOI: 10.1016/j.antiviral.2008.07.009. View

3.
Evans J, Crown R, Sohn J, Seeger C . West Nile virus infection induces depletion of IFNAR1 protein levels. Viral Immunol. 2011; 24(4):253-63. PMC: 3154464. DOI: 10.1089/vim.2010.0126. View

4.
Bhattacharyya S, Zagorska A, Lew E, Shrestha B, Rothlin C, Naughton J . Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe. 2013; 14(2):136-47. PMC: 3779433. DOI: 10.1016/j.chom.2013.07.005. View

5.
Anderson J, Rahal J . Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis. 2001; 8(1):107-8. PMC: 2730275. View